JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Search

Cencora Inc

Gesloten

SectorGezondheidszorg

304.01 -1.18

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

303.23

Max

306.27

Belangrijke statistieken

By Trading Economics

Inkomsten

906M

566M

Verkoop

2.2B

86B

K/W

Sectorgemiddelde

37.19

67.147

EPS

4.08

Dividendrendement

0.73

Winstmarge

0.659

Werknemers

47,000

EBITDA

858M

1B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+32.19% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.73%

2.36%

Volgende Winsten

6 mei 2026

Volgende dividenddatum

1 jun 2026

Volgende Ex Dividend datum

15 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-10B

60B

Vorige openingsprijs

305.19

Vorige sluitingsprijs

304.01

Nieuwssentiment

By Acuity

7%

93%

2 / 347 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 mei 2026, 23:47 UTC

Winsten

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 mei 2026, 22:35 UTC

Winsten

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 mei 2026, 23:39 UTC

Marktinformatie

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 mei 2026, 23:34 UTC

Marktinformatie

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 mei 2026, 23:32 UTC

Winsten

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 mei 2026, 23:30 UTC

Marktinformatie

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 mei 2026, 23:20 UTC

Marktinformatie

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 mei 2026, 23:16 UTC

Acquisities, Fusies, Overnames

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 mei 2026, 22:57 UTC

Acquisities, Fusies, Overnames

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 mei 2026, 22:45 UTC

Marktinformatie

Global Equities Roundup: Market Talk

3 mei 2026, 22:45 UTC

Marktinformatie

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 mei 2026, 22:20 UTC

Winsten

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 mei 2026, 22:08 UTC

Winsten

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 mei 2026, 22:05 UTC

Winsten

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 mei 2026, 22:05 UTC

Winsten

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 mei 2026, 22:05 UTC

Winsten

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 mei 2026, 22:04 UTC

Winsten

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 mei 2026, 22:03 UTC

Winsten

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 mei 2026, 22:03 UTC

Winsten

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 mei 2026, 22:02 UTC

Winsten

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 mei 2026, 22:02 UTC

Winsten

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 mei 2026, 22:02 UTC

Winsten

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 mei 2026, 22:01 UTC

Winsten

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 mei 2026, 22:01 UTC

Winsten

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 mei 2026, 22:01 UTC

Winsten

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 mei 2026, 15:06 UTC

Winsten

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

32.19% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 401.86 USD  32.19%

Hoogste 429 USD

Laagste 360 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

6

Buy

2

Hold

0

Sell

Sentiment

By Acuity

2 / 347 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat